Northern Trust’s Edesa Biotech EDSA Stock Holding History

Northern Trust’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$122K	Hold	14,994	–	–	﹤0.01%	4079
2026 Q1	$78.4K	Buy	+14,994	New	+$45K	﹤0.01%	4159
2023 Q4	–	Sell	-3,220	Closed	-$14.2K	–	4491
2023 Q3	$14.2K	Hold	3,220	–	–	﹤0.01%	4371
2023 Q2	$18.3K	Hold	3,220	–	–	﹤0.01%	4424
2023 Q1	$20.6K	Buy	3,220 +1,027	+47%	+$10.7K	﹤0.01%	4444
2022 Q4	$33.2K	Hold	2,193	–	–	﹤0.01%	4385
2022 Q3	$14K	Hold	2,193	–	–	﹤0.01%	4600
2022 Q2	$25K	Hold	2,193	–	–	﹤0.01%	4585
2022 Q1	$46K	Hold	2,193	–	–	﹤0.01%	4546
2021 Q4	$86K	Hold	2,193	–	–	﹤0.01%	4465
2021 Q3	$113K	Hold	2,193	–	–	﹤0.01%	4370
2021 Q2	$81K	Hold	2,193	–	–	﹤0.01%	4412
2021 Q1	$83K	Buy	+2,193	New	+$88.4K	﹤0.01%	4310

Other funds holding EDSA

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Northern Trust's EDSA Position: Q2 2026 in Review

Northern Trust held its Edesa Biotech (EDSA) position steady in Q2 2026 at 14,994 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #4079.

Northern Trust first reported a position in EDSA in Q1 2021 and has held it in 13 quarters since. 33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

Northern Trust held 14,994 shares of Edesa Biotech worth $122K as of Q2 2026.
Northern Trust left its Edesa Biotech share count unchanged in Q2 2026.
Edesa Biotech made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4079 holding.
Northern Trust first reported a position in Edesa Biotech in Q1 2021 and has held it in 13 quarters since.
33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.